Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.69 USD per share, beating the −1.09 USD estimate by 36.63%. Revenue for the same period reached ‪268.00 M‬ USD, despite the estimate of ‪189.10 M‬ USD. For the next quarter, analysts expect −1.21 USD in earnings per share and ‪182.36 M‬ USD in revenue.

Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise